GlaxoSmithKline(MX:GSK1N)
MX$468.000.00 (0.00%)
MX:GSK1N
GlaxoSmithKline earnings date
MX$468.00
At close:0.00 (0.00%)
GlaxoSmithKline (GSK1N) Q3 2022 Earnings Report
0 Followers
MX:GSK1N Q3 2022 EPS Results
- Actual EPS
- MXN 11.75
- Consensus EPS
- MXN 7.62
- Beat/Miss
- Beat by +MXN 4.13
- One Year Ago EPS
- MXN 9.27
MX:GSK1N Q3 2022 Revenue Results
- Actual Revenue
- MXN 196.19B
- Expected Revenue
- MXN 140.97B
- Beat/Miss
- Beat by +MXN 55.22B
- YoY Revenue Growth
- -13.75%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/02/2022
- Time
- Before Open
- Conference Call
- Wednesday, November 2, 2022
MX:GSK1N Upcoming Earnings
GlaxoSmithKline's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:GSK1N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 6.92- | 6.39 | ― | ― |
| Oct 28, 2026 | 2026 (Q3) | 12.6013.68 | 13.78 | -0.73% (-0.10) | |
| Jul 28, 2026 | 2026 (Q2) | 11.6512.65 | 11.65 | 8.60% (+1.00) | |
| Apr 29, 2026 | 2026 (Q1) | 10.8011.65 | 11.25 | 3.56% (+0.40) | |
| Feb 04, 2026 | 2025 (Q4) | 5.966.39 | 5.81 | 9.91% (+0.58) | |
| Oct 29, 2025 | 2025 (Q3) | 11.7813.78 | 12.45 | 10.66% (+1.33) | |
| Apr 30, 2025 | 2025 (Q1) | 10.0211.25 | 10.8 | 4.18% (+0.45) | |
| Feb 05, 2025 | 2024 (Q4) | 4.965.81 | 7.24 | -19.72% (-1.43) | |
| Oct 30, 2024 | 2024 (Q3) | 11.0012.45 | 12.63 | -1.39% (-0.18) | |
| Jul 31, 2024 | 2024 (Q2) | 9.5710.88 | 9.72 | 11.86% (+1.15) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

